Premium
Xenetic Biosciences Inc (XBIO)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual ... Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a pipeline of therapeutic assets targeting oncology indications. It also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin resistant endometrial cancer. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.279 | 7.207439938 | 3.871 | 4.32 | 3.81 | 5545 | 4.07195869 | CS |
| 4 | -0.13 | -3.03738317757 | 4.28 | 4.32 | 3.81 | 9952 | 4.11682263 | CS |
| 12 | 0.43 | 11.5591397849 | 3.72 | 4.65 | 3.58 | 23039 | 4.05573284 | CS |
| 26 | -0.19 | -4.37788018433 | 4.34 | 5.2 | 2.78 | 19184 | 3.9786599 | CS |
| 52 | 0.49 | 13.3879781421 | 3.66 | 5.2 | 2.78 | 12303 | 3.99320036 | CS |
| 156 | -8.25 | -66.5322580645 | 12.4 | 12.5 | 2.40101 | 45706 | 7.10046241 | CS |
| 260 | -10.95 | -72.5165562914 | 15.1 | 58.5 | 2.40101 | 826500 | 28.00965596 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
